|
Commercial Product |
FDA Precaution |
Web page |
|
TOPICAL |
| Androgel ®
AbbVie Inc.
North Chicago, IL |
Large doses of exogenous androgens may lead to suppression of spermatogenesis or azoospermia through feedback inhibition of pituitary FSH. This could possibly lead to adverse effects on semen parameters, including sperm count. |
http://www.androgel.com/default.aspx |
| Androderm®
Watson Pharmaceuticals, Inc.
Oakville, Ontario, Canada |
Taking testosterone may lead to a condition in which there are no sperm in the semen |
http://www.androderm.com/ |
| Testim®
Auxilium Pharmaceuticals, Inc.
Malvern, PA |
At large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle-stimulating hormone (FSH).
In large doses, Testim may lower your sperm count. |
http://www.testim.com/ |
| Fortesta®
Endo Pharmaceuticals Inc. Malvern, PA |
With large doses of exogenous androgens, includingFortesta, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle-stimulating hormone, which could possibly lead to adverse effects on semen parameters including sperm count.
In large doses, Fortesta may lower your sperm count.
The administration of exogenous testosterone has been reported to suppress spermatogenesis in the rat, dog, and non-human primates which was reversible on cessation of the treatment. |
http://www.fortestagel.com/ |
| Axiron®
Lilly USA, LLC.
Indianapolis, IN |
At large doses, spermatogenesis may be suppressed which could possibly lead to adverse effects on semen parameters including, sperm count. |
http://www.axironmd.com/Pages/home.aspx |
| BUCCAL |
| Striant®
Mipharm S.p.A
Milan, Italy |
During exogenous administration of androgens, endogenous testosterone release may be inhibited through feedback inhibition of pituitary luteinizing hormone (LH). At large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle-stimulating hormone (FSH). |
http://www.actientpharma.com/filebin/pdf/products/58816-10_Striant_full_PI_4pager.pdf |
| INTRAMUSCULAR/SUBCUTANEOUS |
| Testosterone enanthate
Hikma Pharmaceutical (Portugal), S.A. |
During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). Large doses of exogenous androgens may suppress spermatogenesis through inhibition of pituitary follicle stimulating hormone (FSH). |
http://www.drugs.com/pro/testosterone-enanthate.html |
| Testosterone cypionate
West-ward pharmaceutical corp. Eatontown, NJ 07724 USA |
Exogenous administration of androgens may lead to azoospermia. |
http://www.drugs.com/pro/testosterone-cypionate.html |
Testopel® Slate Pharmaceuticals Inc.
Durham, NC |
During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). At large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH). |
http://www.testopel.com/ |
